Q2 FY26 weak, auditor flags WIP issue, Rs 199.92 cr promoter warrant plan

Emphasis of matterResults restatedExceptional itemRevenue declinedNet loss reportedResults View source PDF Explain this filing

RKFORGE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+1.9%Reaction day

₹539.00

prior close

₹533.00

announcement price

After-mkt

timing

Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.4%+2.3% vs market

Auto Components & Equipments peers, median of 110sector-0.4%+2.3% vs sector

On the reaction day the stock moved 2.3 pts more than Nifty Smallcap 250 and 2.3 pts more than its Auto Components & Equipments peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+6.0

10m

+7.4

15m

+8.1

30m

+8.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+1.9-0.4+2.3-0.4+2.3

Next day

+2.2-0.2+2.4-0.3+2.5

+2.7+0.5+2.3-0.2+2.9

+0.6-0.6+1.1-0.7+1.3

-0.4-1.0+0.6-1.0+0.6

+0.2-1.1+1.3-1.8+2.0

-4.1-2.9-1.2-4.2+0.1

15d

-1.5-3.1+1.7-4.0+2.5

-3.5-3.9+0.4-4.8+1.3

-7.6-5.3-2.3-8.5+0.9

+4.8-6.6+11.4-4.3+9.2

UpDownMarket · Nifty Smallcap 250Sector · Auto Components & Equipments peers, median of 110Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Ramkrishna Forgings Q2 FY26 was weak. Standalone revenue dropped to Rs 800.79 cr vs Rs 936.69 cr YoY (restated); PAT was Rs 0.37 cr. Consolidated Q2 swung to a Rs 9.50 cr loss. H1 standalone PAT was Rs 21.88 cr vs Rs 178.64 cr restated. Auditors flagged emphasis of matter on WIP discrepancies, restating prior periods. Board approved 34 lakh warrants to promoter at Rs 588, raising Rs 199.92 cr, pending EGM on Dec 12.

Likely market impact

Weak results, pat plunge, and WIP restatement raise concerns. Promoter warrant infusion of about Rs 200 cr signals confidence. Watch Dec 12 EGM.